Ensign Peak Advisors’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Hold
3,802
﹤0.01% 1195
2026
Q1
$307K Hold
3,802
﹤0.01% 1115
2025
Q4
$290K Sell
3,802
-5,500
-59% -$422K ﹤0.01% 1127
2025
Q3
$740K Sell
9,302
-7,700
-45% -$576K ﹤0.01% 1193
2025
Q2
$1.19M Hold
17,002
﹤0.01% 1140
2025
Q1
$1.26M Hold
17,002
﹤0.01% 1122
2024
Q4
$1.18M Hold
17,002
﹤0.01% 1219
2024
Q3
$1.43M Hold
17,002
﹤0.01% 1110
2024
Q2
$1.15M Hold
17,002
﹤0.01% 1196
2024
Q1
$1.07M Sell
17,002
-858
-5% -$48.4K ﹤0.01% 1272
2023
Q4
$997K Buy
17,860
+1,700
+11% +$90K ﹤0.01% 1382
2023
Q3
$830K Hold
16,160
﹤0.01% 1338
2023
Q2
$847K Hold
16,160
﹤0.01% 1393
2023
Q1
$834K Buy
16,160
+800
+5% +$43.6K ﹤0.01% 1395
2022
Q4
$802K Buy
15,360
+9,650
+169% +$529K ﹤0.01% 1343
2022
Q3
$323K Buy
+5,710
New +$360K ﹤0.01% 1674

Other funds holding NHI

Ensign Peak Advisors's NHI Position: Q2 2026 in Review

Ensign Peak Advisors held its National Health Investors (NHI) position steady in Q2 2026 at 3,802 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #1195.

Ensign Peak Advisors first reported a position in NHI in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.43M in Q3 2024. 297 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Ensign Peak Advisors held 3,802 shares of National Health Investors worth $290K as of Q2 2026.
  • Ensign Peak Advisors left its National Health Investors share count unchanged in Q2 2026.
  • National Health Investors made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1195 holding.
  • Ensign Peak Advisors first reported a position in National Health Investors in Q3 2022 and has held it in 16 quarters since.
  • Ensign Peak Advisors's National Health Investors position peaked at $1.43M in Q3 2024.
  • 297 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.